AllianceBernstein
ETON icon

AllianceBernstein’s Eton Pharmaceutcials ETON Stock Holding History

AllianceBernstein’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$697K Buy
+28,250
New +$828K ﹤0.01% 2544
2025
Q4 		– Sell
-9,600
Closed -$209K – 3253
2025
Q3 		$209K Buy
+9,600
New +$159K ﹤0.01% 3067

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

AllianceBernstein's ETON Position: Q2 2026 in Review

AllianceBernstein opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 28,250 shares worth $697K. The stake represents ﹤0.01% of the portfolio and ranks #2544 among its holdings. This is a return to the name: AllianceBernstein previously reported a position in ETON as recently as Q3 2025.

AllianceBernstein first reported a position in ETON in Q3 2025 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • AllianceBernstein held 28,250 shares of Eton Pharmaceutcials worth $697K as of Q2 2026.
  • Eton Pharmaceutcials was a new AllianceBernstein position in Q2 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2544 holding.
  • AllianceBernstein first reported a position in Eton Pharmaceutcials in Q3 2025 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.